Biopharmaceuticals

#ADME / Tox #Biopharmaceuticals #Drug toxicity #Endotoxins

EtoxiClear®: Optimising endotoxin removal

In this Technical Note you will learn more about: Targeted and efficient endotoxin removal: EtoxiClear® is a highly effective chromatography affinity adsorbent, specifically designed to remove low residual levels of endotoxins across a variety of biopharmaceutical processes, ensuring high product purity Scalability and cost-effectiveness: Designed for both small and large-scale… Read More

#Resources

#3D cell culture #Assay development optimisation & technology #Biopharmaceuticals #Cell line development #Cell lines #Cell Science #Guide

DDW Cell Line Development Guide 2024

Download the exclusive Guide and read about: What are the benefits cell line development is bringing to biopharmaceutical developers? What technological advances are helping drive efficiencies in cell line development? How is this process underpinning drug development and why is the market growing? In what ways is cell line development… Read More

#DDW eBooks #DDW Guides

Laboratory research
#Biopharma #Biopharmaceuticals #Career #Great Place To Work

Biopharma amongst top-ranking sectors for employee wellbeing

Biopharma ranks amongst the highest scoring sectors for employee wellbeing and comes top for work-life balance and self-care, according to a survey conducted by Great Place To Work. Leveraging their research-based Trust Index Survey, Great Place To Work conducted a UK population study, surveying 2,200 employees… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automated workflows #Automation #Automation / robotics #Biopharma #Biopharmaceuticals #Data science #Drug development #Drug discovery #Lab automation #Lab technology #Personalised medicine #Pharmaceuticals

New podcast: How technology is impacting drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and… Read More

#News

GBP pound sterling funding
#Biopharmaceuticals #Biotechnology #Finance #Investment #mRNA #Novo Holdings #Oxford Nanopore Technologies

Investing in a new generation of molecular analysis technology 

Novo Holdings has announced a £5 million investment in Oxford Nanopore Technologies as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market, subject to availability and price (among other factors).  Oxford Nanopore has developed a new generation of… Read More

#Business & Investment #News

#Biopharma #Biopharmaceuticals #GlobalData #Market reporting

Biopharma industry optimistic about growth in the next year

The biopharmaceutical industry is revealing increasing optimism regarding its growth prospects over the next 12 months. While the upward trend is a positive sign, it remains below the levels of confidence seen in 2022, finds data and analytics company GlobalData. In a recent survey, ‘The State of the Biopharmaceutical Industry 2024… Read More

#Business & Investment #News

#3D cell culture #Assay development optimisation & technology #Biopharmaceuticals #Cell line development #Cell lines #Cell Science

Advances in cell line development

Reece Armstrong offers an overview of cell line development and outlines the benefits the technology is bringing to biopharmaceutical developers. Cell line development is an essential underpinning of the drug development process, enabling teams to test, optimise and manufacture therapeutics at a commercial scale. It is a crucial for the… Read More

#Exclusive Content

#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Environmental monitoring within biotherapeutic production

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Understand microbial control in biotherapy production

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biomanufacturing #Biopharmaceuticals #GMP #Microbiology #QA/QC #Webinar

Implementing rapid microbial identification in biotherapy manufacturing

Join DDW for this free on-demand event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. It is presented by Phil Tuckett, BS, RM(NRCM, Department Scientist, Nelson Laboratories and Michelle Thai, Technical Sales Specialist, Pharma… Read More

Webinar date:
Brought to you by Thermo Fisher Scientific
#Webinars

Bacteria
#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Microbial identification in biotherapy manufacturing

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biomanufacturing #Biopharmaceuticals #Events #GMP #Microbiology #QA/QC #Webinar

Webinar: Enhancing quality control in biotherapy manufacturing

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance, which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10… Read More

#News

#Biopharmaceuticals #Clinical trials #Diabetes #Diabetic macular oedema #Eye health #Retinopathy

Investigating potential for an oral treatment in diabetic retinopathy  

Breye Therapeutics, a clinical-stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases within ophthalmology, has started a Phase Ib/IIa clinical trial to investigate danegaptide, following oral administration, in patients suffering from diabetic macular oedema (DMO).  Breye is developing novel, oral ophthalmology drugs fordiabetic retinopathy (DR)… Read More

#News

#Biopharmaceuticals #Clarivate #Drug development #Drug discovery #Market reporting

Thirteen potential blockbuster drugs to watch in 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. They include therapeutics for conditions including breast cancer, haemophilia A, sickle cell disease, Crohn’s disease, ulcerative colitis, respiratory syncytial virus (RSV) and multiple myeloma, among others. The predictions were… Read More

#News #Trending News #Trends & Analysis

Oligonucleotide
#Alpha-1 antitrypsin deficiency #Biopharmaceuticals #Genetic medicines #Korro Bio #Oligonucleotides #RNA

RNA editing oligonucleotide selected for AATD treatment 

Korro Bio, a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases, has nominated its first development candidate, KRRO-110, for the potential treatment of alpha-1 antitrypsin deficiency (AATD).   KRRO-110 is an RNA editing oligonucleotide delivered to liver cells… Read More

#News

#AI / data analytics / healthtech / informatics #Big pharma #BioNTech #Biopharmaceuticals #Comirnaty #Covid-19 #Drug discovery #Healthcare #Moderna #mRNA #Pfizer

New podcast on drug discovery trends

This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and… Read More

#News